Novavax’s 3,500% Surge on a Covid-19 Vaccine Faces First Test

Novavax’s 3,500% Surge on a Covid-19 Vaccine Faces First Test

Novavax’s 3,500% Surge on a Covid-19 Vaccine Faces First Test

(Bloomberg) — Novavax Inc.’s Covid-19 vaccine results are expected imminently and scientists will be scanning the data to gauge the shot’s promise.

By Miki